China Dasheng Biotechnology Company
CDBTOTCFinancial Services
$0.10
+$0.00(+0.00%)
Market Cap$4097600
P/E Ratio—
52W High$0.15
52W Low$0.0003
China Dasheng Biotechnology Company（CDBT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CDBT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-06 | 2008-06 | 2007-10 | 2006-10 | 2005-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.02B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.01B | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 46.05% | — | 24.71% | 35.52% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | $0.01B | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | 31.15% | — | -3.48% | -3.61% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | $0.01B | ($0.00B) | $0.00B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | 28.46% | — | -3.48% | -3.61% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $0.15 | $-0.01 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 0.04B | 0.03B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.00B) | $0.01B | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | 34.99% | — | -3.14% | -3.35% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解China Dasheng Biotechnology Company
关于China Dasheng Biotechnology Company（CDBT）损益表
China Dasheng Biotechnology Company（CDBT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，CDBT实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.00B)（净利率—）。
常见问题
CDBT · 4 问China Dasheng Biotechnology Company（CDBT）2023财年营收为$0.00B，同比down100.0%。
CDBT revenueCDBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08